Gian Life Care Ltd.

21.00 -0.20 ▼-0.9%

09 June 2023, 04:01:00 PM
Volume: 28,255

Company Profile

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.gianpathlabs.com
Market Cap 21.75 Cr.
Enterprise Value(EV) 26.32 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 1.03 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 20.41 Trailing Twelve Months Ending 2023-03
Industry PE 49.44 Trailing Twelve Months Ending 2023-03
Book Value / Share 13.56 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.55 Calculated using Price: 21.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.03 Cr. 10,341,527 Shares
FaceValue 10
About Gian Life Care Ltd.
The company is engaged in the business of providing diagnostic and related healthcare services. The company provides a wide range of diagnostic tests and services like patient diagnosis services, prevention, and wellness diagnosis services to patients and healthcare providers. The company caters to individual patients, hospitals, corporates and other healthcare providers. The company offers various tests including biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, histopathology, immunoassay, microbiology, molecular biology, and radiology services.

Gian Life Care Ltd. Delivery

Delivered Qty
Traded Qty

Gian Life Care Ltd. Performance

1 Day
-0.94%
1 Week
-3.71%
1 Month
-13.76%
3 Month
+0.86%
6 Month
-3.00%
1 Year
+14.75%
2 Year
+81.19%
5 Year
10 Year

Gian Life Care Ltd. Fundamental Ratios

1 years 2022-03
Return on Equity (%) 31.16
Return on Capital Employed (%) 44.24
Return on Assets (%) 18.95

Gian Life Care Ltd. Balance Sheet

Particulars 2 years 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 14 15
Non Curr. Liab. 2 2
Curr. Liab. 7 11
Minority Int.
Equity & Liab. 23 28
Non Curr. Assets 13 17
Curr. Assets 10 11
Misc. Exp. not W/O
Total Assets 23 28

Gian Life Care Ltd. Profit and Loss

Particulars 1 years 2022-03 Rs. Cr.
Net Sales 16
Other Income 1
Total Income 16
Total Expenditure -9
PBIDT 7
Interest -1
Depreciation 0
Taxation -1
Exceptional Items
PAT 4
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 4
Adjusted EPS 4

Gian Life Care Ltd. Cash Flow

Particulars 1 years 2022-03 Rs. Cr.
Cash Fr. Operatn. 6
Cash Fr. Inv. -4
Cash Fr. Finan. 1
Net Change 2
Cash & Cash Eqvt 5

Gian Life Care Ltd. Shareholding Pattern

7 Qtrs 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2022-03 (%) 2022-09 (%) 2023-03 (%)
Promoter 69.87 69.87 69.87 69.87 64.95 60.77 56.90
Public 30.13 30.13 30.13 30.13 35.05 39.23 43.10
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Gian Life Care Ltd. Announcements

Fri, 02 Jun 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the provisions of Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith copies of newspaper publications published on June 01 2023 regarding publication of Audited Standalone and Consolidated Financial results of the Company for the quarter/ half year and year ended 31st March 2023. You are requested to kindly take the above information in your records.Thanking You Yours faithfully For GIAN LIFE CARE LIMITED
Tue, 30 May 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday May 30 2023
Pursuant to the provisions of Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today i.e. 30th May 2023 has inter-alia considered and approved the following:-1. Audited Standalone and Consolidated Financial results of the Company for the quarter/ half year and year ended 31st March 2023. (Copy enclosed along with Audit Report). The Board Meeting commenced at 05:30 P.M and concluded at 07.15 P.M.The above information shall also be made available on the website of the Company at https://gianlifecare.org/.You are requested to kindly take the above information in your records.Thanking You Yours faithfully For GIAN LIFE CARE LIMITED
Tue, 30 May 2023
Results - Financial Year March 31 2023
Pursuant to the provisions of Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today i.e. 30th May 2023 has inter-alia considered and approved the following:-1. Audited Standalone and Consolidated Financial results of the Company for the quarter/ half year and year ended 31st March 2023. (Copy enclosed along with Audit Report). The Board Meeting commenced at 05:30 P.M and concluded at 07.15 P.M.The above information shall also be made available on the website of the Company at https://gianlifecare.org/.You are requested to kindly take the above information in your records.Thanking You Yours faithfully For GIAN LIFE CARE LIMITED

Gian Life Care Ltd. Technical Scans

Fri, 09 Jun 2023
High Delivery Percentage High Delivery Percentage
Making Lower Lows for 3 days Making Lower Lows for 3 days
S Making Lower Lows for 2 Days
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 2 Years High Increase in 2 Years

Gian Life Care Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,890.62 983.15 -0.4%
Divi's Laboratories Ltd. 90,973.43 3,426.90 -2.1%
Cipla Ltd. 78,191.79 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. 77,768.81 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. 70,817.54 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. 61,150.32 1,810.90 +0.8%
Mankind Pharma Ltd. 59,389.24 1,482.30 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.84 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 49.89 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 27.91 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.25 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.63 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 49.23 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 46.32 1,482.30 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7.13 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 3.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.34 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.46 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.89 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 5.05 1,482.30 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 0.04 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 0.14 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 7,781.56 1,482.30 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 1,452.96 1,482.30 +1.8%

Gian Life Care Ltd. FAQ's

What is Gian Life Care share price?

Can I buy Gian Life Care shares now?

What is the Market Cap of Gian Life Care?

What are the key metrics to analyse Gian Life Care?

What is the 52 Week High and Low of Gian Life Care?

What is the trend of Gian Life Care share price?